Overview

Magen BioSciences, Inc. (Waltham, MA) is focused on identifying and developing novel pharmaceutical products that improve the health and appearance of human skin.  The company’s science-driven approach is grounded in a deep understanding of the underlying biology of normal and diseased skin.  Through internal research and development, partnerships, and collaborations, Magen is bringing forth an innovative portfolio of products to treat a number of large, poorly served dermatological disorders.

The company was founded in 2006 by a renowned group of individuals, including co-founders of Idexx, Immunex, Alnylam, Sirtris Pharmaceuticals, Momenta, Vertex, Biogen and Genzyme.  The company established a state-of-the-art research and development capability to evaluate drug candidates across a number of dermatological disorders.  In 2007 Magen in-licensed from Eli Lilly & Co. a portfolio of novel, small molecule drug candidates with potential utility in a variety of dermatological disorders.